Cold-EEZE® Announces Launch of NEW Cold-EEZE® Cold Remedy Daytime/Nighttime QuickMelts® and achieves Nationwide Product Distribution
ProPhase Labs, Inc. (NASDAQ: PRPH) announces launch their first-ever Cold-EEZE Cold Remedy Daytime/Nighttime QuickMelt tablets.
In addition to the QuickMelts' nationwide availability, the Cold-EEZE Oral Spray has gone from an initial distribution in the 2011/2012 cough & cold season to full national distribution for the upcoming 2012/2013 cough & cold season. Two sprays deliver the same amount of cold remedy (active ingredient zinc gluconate) as in one Cold-EEZE Lozenge. The recommended two sprays per usage offer 13.3 mg of zinc gluconate and each bottle contains at least 45 doses (90 sprays), providing excellent value.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.